CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
CHAMPIONS ONCOLOGY, INC.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026
$4.69−0.01 (-0.21%)
Close on Oct 19, 2026
- Market cap
- $65.18M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Champions Oncology's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 14, 2026 | Oct 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2026 | Sep 11, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2026 | Sep 10, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 27, 2026 | Aug 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Apr 30, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 27, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2026 | Mar 30, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2026 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Oct 31, 2025 | Dec 15, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 15, 2025 | Dec 15, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2025 | Oct 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2025 | Sep 15, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2025 | Sep 15, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 22, 2025 | Aug 22, 2025 | SEC EDGAR |
| Annual report | 10-K | Apr 30, 2025 | Jul 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2025 | Jul 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 21, 2025 | Jul 21, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2025 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Oct 31, 2024 | Dec 16, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 11, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2024 | Oct 15, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 3, 2024 | Oct 3, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2024 | Sep 13, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2024 | Sep 11, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 27, 2024 | Aug 27, 2024 | SEC EDGAR |
| Annual report | 10-K | Apr 30, 2024 | Jul 19, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 18, 2024 | Jul 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2024 | Mar 15, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2024 | Mar 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Oct 31, 2023 | Dec 13, 2023 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2023 | Dec 12, 2023 | SEC EDGAR |
| Current report | 8-K | Oct 19, 2023 | Oct 19, 2023 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2023 | Oct 17, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2023 | Sep 13, 2023 | SEC EDGAR |
| Current report | 8-K | Sep 13, 2023 | Sep 13, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 28, 2023 | Aug 28, 2023 | SEC EDGAR |
| Annual report | 10-K | Apr 30, 2023 | Jul 24, 2023 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2023 | Jul 24, 2023 | SEC EDGAR |